Clinical, Laboratory and Molecular Findings of 63 Patients with Severe Combined Immunodeficiency: A Decade's Experience

Autor: MR Fazlollahi, Z Pourpak, AA Hamidieh, M Movahedi, M Houshmand, M Badalzadeh, M Nourizadeh, M Mahloujirad, S Arshi, AM Nabavi, M Gharagozlou, A Khayatzadeh, A Dabbaghzade, L Atarod, F Zandieh, M Sadeghi Shabestary, M Mesdaghi, I Mohammadzadeh, SA Mahdaviani, MH Eslamian, F Pesaran, E Bahraminia, F Abolnezhadian, Z Arij, M Moin

Publikováno v: Journal of Investigational Allergology and Clinical Immunology.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c5b9bb3353640d625cb2c9cbcb2dd84f
https://doi.org/10.18176/jiaci.0047

Hematopoietic Stem Cell Transplantation for C1q Deficiency: A Study on Behalf of the EBMT Inborn Errors Working Party.

Autor: Buso H; Department of Medicine (DIMED), University of Padova, Padua, Italy.; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK., Adam E; Sheba Medical Center, The Edmond and Lily Safra Children's Hospital, Ramat Gan, Israel., Arkwright PD; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK., Bhattad S; Division of Paediatric Immunology and Rheumatology, Department of Paediatrics, Aster CMI Hospital, Bengaluru, India., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Behfar M; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Belot A; Department of Paediatric Rheumatology, Femme-Mère-Enfant Hospital, HCL, Lyon, France., Benezech S; Institute of Hematology and Pediatric Oncology, 69008, Lyon, France., Chan AY; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, CA, USA., Crow YJ; Laboratory of Neurogenetics and Neuroinflammation, Imagine Institute, INSERM UMR1163, Paris, France.; MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Dvorak CC; Division of Pediatric Allergy, Immunology, and Blood and Marrow Transplant, UCSF Benioff Children's Hospital, University of California San Francisco, San Francisco, CA, USA., Flinn AM; Department of Pediatric Immunology, Children's Health Ireland at Crumlin, Dublin, Ireland., Kapoor U; Division of of Pediatrics Haematology, Oncology and Stem Cell Transplant, Children's Hospital New York-Presbyterian, Columbia University, 161 Fort Washington, Irving 7, New York, NY, 10032, USA., Lankester A; Department of Pediatrics, Willem-Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands., Kobayashi M; Department of Pediatrics, Hiroshima University Hospital, 1‑2‑3 Kasumi, Minami‑ku, Hiroshima, 734‑8551, Japan., Matsumura R; Department of Pediatrics, Hiroshima University Hospital, 1‑2‑3 Kasumi, Minami‑ku, Hiroshima, 734‑8551, Japan., Mottaghipisheh H; Hematology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran., Okada S; Department of Pediatrics, Hiroshima University Hospital, 1‑2‑3 Kasumi, Minami‑ku, Hiroshima, 734‑8551, Japan., Ouachee M; Institute of Hematology and Pediatric Oncology, 69008, Lyon, France., Parvaneh N; Division of Allergy and Clinical Immunology, Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran., Ramprakash S; Aster International Institute of Oncology, Aster CMI Hospital, Bangalore, India., Satwani P; Division of of Pediatrics Haematology, Oncology and Stem Cell Transplant, Children's Hospital New York-Presbyterian, Columbia University, 161 Fort Washington, Irving 7, New York, NY, 10032, USA., Sharafian S; Department of Allergy and Clinical Immunology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Triaille C; Pôle de Pathologies Rhumatismales Systémiques Et Inflammatoires, Institut de Recherche Expérimentale Et Clinique, Université Catholique de Louvain, Brussels, Belgium.; Pediatric Immunology and Rheumatology Division, Department of Pediatrics, CHU Sainte-Justine, University of Montreal, Montreal, QC, Canada., Wynn RF; Department of Paediatric Haematology & Oncology, Royal Manchester Children's Hospital, Manchester, UK., Movahedi N; Golestan Rheumatology Research Center (GRRC), Golestan University of Medical Sciences, Gorgan, Iran.; Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran., Ziaee V; Pediatric Rheumatology Research Group, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.; Department of Pediatrics, Tehran University of Medical Sciences, Tehran, Iran., Williams E; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK., Slatter M; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK.; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK., Gennery AR; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle Upon Tyne, NE1 4LP, UK. andrew.gennery@newcastle.ac.uk.; Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK. andrew.gennery@newcastle.ac.uk.

Publikováno v: Journal of clinical immunology [J Clin Immunol] 2024 Oct 29; Vol. 45 (1), pp. 35. Date of Electronic Publication: 2024 Oct 29.

Phase I study of safety and efficacy of allogeneic natural killer cell therapy in relapsed/refractory neuroblastomas post autologous hematopoietic stem cell transplantation.

Autor: Mohseni R; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Mahdavi Sharif P; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Behfar M; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Shojaei S; National Institute of Genetic Engineering and Biotechnology, Tehran, Iran., Shoae-Hassani A; Stem Cell and Regenerative Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran., Jafari L; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Khosravi A; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Nikfetrat Z; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran University of Medical Sciences, Tehran, 14194, Iran. aahamidieh@tums.ac.ir.

Publikováno v: Scientific reports [Sci Rep] 2024 Sep 09; Vol. 14 (1), pp. 20971. Date of Electronic Publication: 2024 Sep 09.

Special Report: Summary of the eighth workshop of the worldwide network for blood and marrow transplantation on the status and issues related to hematopoietic stem cell transplantation in near-east countries, held in Pakistan from September 22 to 23, 2022.

Autor: Greinix HT; Division of Hematology, Medical University Graz, Graz, Austria., Iftikhar R; Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan., Chaudhry QUN; Armed Forces Bone Marrow Transplant Centre, Rawalpindi, Pakistan., Ahmed P; Quaid-e-Azam International Hospital, Islamabad, Pakistan., Al-Khabori M; Hematology Department, Sultan Qaboos University Hospital, Muscat, Oman., Gaziev J; Hematology Department, National Center for Cancer Care & Research, Hamad Medical Corporation, Doha, Qatar., Hamidieh AA; Tehran University of Medical Sciences, Pediatric Cell and Gene Therapy Research Center, Gene, Cell & Tissue Research Institute, Tehran, Iran., Hashmi S; Department of Medicine, Khalifa University, SSMC, Abu Dhabi, United Arab Emirates.; College of Medical and Health Sciences, Abu Dhabi, United Arab Emirates., Khan M; BMT Unit, Department of Hematology, Dhaka Medical College Hospital, Dhaka, Bangladesh., Poudyal BS; Civil Service Hospital, Hematology and Bone Marrow Transplant Services, Kathmandu, Nepal., Shaheen M; King Faisal Specialist Hospital and Research Centre, Department of Hematology, SCT and Cellular Therapy, Riyadh, Saudi Arabia., Rasheed W; King Faisal Specialist Hospital and Research Centre, Oncology Center, Riyadh, Saudi Arabia., Galeano S; Hospital Británico, Montevideo, Uruguay., Kodera Y; Department of Promotion for Blood and Marrow Transplantation, Aichi Medical University School of Medicine, Nagakute, Japan., Niederwieser D; Division of Hematology and Medical Oncology, University of Leipzig, Leipzig, Germany., Ahmed SO; King Faisal Specialist Hospital and Research Center, Oncology Center Riyadh, Riyadh, Saudi Arabia., Atsuta Y; Aichi Medical University School of Medicin, Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan.; Department of Registry Science for Transplant and Cellular Therapy, Aichi, Japan., Baldomero H; University Hospital Basel, the Worldwide Network of Blood and Marrow Transplantation (WBMT) Transplant Activity Survey Office, Basel, Switzerland., Frutos C; Central Hospital of the Instituto de Prevision Social, Instituto Nacional de Ablacion y Trasplantes, Department of Hematology, Asuncion, Paraguay., Iida M; Aichi Medical University School of Medicine, Department of Promotion for Blood and Marrow Transplantation, Nagakute, Japan., Okamoto S; Department of Medicine, Keio University School of Medicine, Tokyo, Japan., Rondelli D; Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL, USA., Schwartz J; Moffitt Cancer Center, Transfusion Services, Tampa, FL, USA., Seber A; Department of Medicine, Universidade Federal de Sao Paulo Escola Paulista de Medicina, Sao Paulo, Brazil., Weisdorf D; Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA., Worel N; Department of Blood Group Serology and Transfusion Medicine, Medical University Vienna, Vienna, Austria., Chatzixiros E; Department of Health Products Policies and Standards, WHO Headquarters, Geneva, Switzerland., Koh MB; University of London, Institute for Infection and Immunity, St. George's, London, United Kingdom., Aljurf M; King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Saudi Arabia.

Publikováno v: Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2024 Jul-Sep 01; Vol. 17 (3), pp. 190-199. Date of Electronic Publication: 2024 Oct 04.

Successful allogeneic stem cell transplantation with a reduced-intensity conditioning in a case of leukocyte adhesion deficiency type III.

Autor: Barhoom D; Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran; Pediatric Hematopoietic Stem Cell Transplant Center, Children's Hospital, Damascus University, Damascus, Syria., Behfar M; Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Mohseni R; Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran., Hamidieh AA; Pediatric Cell and Gene Therapy Research Center, Gene, Cell and Tissue Research Institute, Tehran University of Medical Sciences, Tehran, Iran. Electronic address: aahamidieh@tums.ac.ir.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2024 Jul-Sep; Vol. 46 (3), pp. 300-302. Date of Electronic Publication: 2022 Feb 15.